Major Depressive Episode
Also known as: Depressive; Episode, Major
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06594 | Agomelatine | Agomelatine is indicated to treat major depressive episodes in adults. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06594 | Agomelatine | 5-hydroxytryptamine receptor 2C | target |
| DB06594 | Agomelatine | Melatonin receptor type 1B | target |
| DB06594 | Agomelatine | Melatonin receptor type 1A | target |
| DB06594 | Agomelatine | Cytochrome P450 2C9 | enzyme |
| DB06594 | Agomelatine | Cytochrome P450 1A2 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00083 | Botulinum toxin type A | 1 | Withdrawn | 1 |
| DB01221 | Ketamine | 1 | Completed | 1 |
| DB00683 | Midazolam | 1 | Completed | 1 |
| DB09153 | Sodium chloride | 1 | Withdrawn | 1 |
| DB01221 | Ketamine | 1 / 2 | Completed | 1 |
| DB00683 | Midazolam | 1 / 2 | Completed | 1 |
| DB00215 | Citalopram | 2 | Terminated | 1 |
| DB01221 | Ketamine | 2 | Unknown Status | 2 |
| DB00683 | Midazolam | 2 | Unknown Status | 1 |
| DB15490 | Zuranolone | 2 | Completed | 1 |
| DB01221 | Ketamine | 2 / 3 | Completed | 1 |
| DB00921 | Buprenorphine | 3 | Recruiting | 1 |
| DB01221 | Ketamine | 3 | Recruiting | 1 |
| DB00683 | Midazolam | 3 | Recruiting | 1 |
| DB00215 | Citalopram | 4 | Terminated | 1 |
| DB01221 | Ketamine | 4 | Completed | 1 |
| DB00285 | Venlafaxine | 4 | Completed | 1 |
| DB00246 | Ziprasidone | 4 | Completed | 1 |
| DB04272 | Citric acid | Not Available | Recruiting | 1 |
| DB11823 | Esketamine | Not Available | Recruiting | 1 |
| DB01221 | Ketamine | Not Available | Recruiting | 1 |
| DB14509 | Lithium carbonate | Not Available | Recruiting | 1 |